Cohort plc reported revenue and adjusted operating profit ahead of expectations for the year ended 30 April 2026. Revenue rose to £303m and adjusted profit reached c.£36m, driven by its Communications and Intelligence division.
Operating profit was maintained at £0.4m despite a 22.4% decline in revenue; The company achieved planning on approximately 800 new living units and grew its Development Partnership and Refresh pipeline by 20%.
Drax Group confirmed Chief Financial Officer Frank Lemmink has returned to work following a health-related leave of absence. Deputy CFO Daniel Peacock served as interim CFO during the period.
Europa Oil & Gas reported a pre-tax loss of £2.7m for the 17-month period to December 2025. The company secured a farm-out for its Equatorial Guinea asset with a $53m cost carry and completed a post-period £4.1m equity raise.
Jangada Mines reported high-grade gold, silver, and copper intersections at its Molly Gold Project in Brazil. Drilling at Molly 1 extended the mineralised envelope by 100-150m, while hole 7A confirmed a new discovery at the Molly 2 target.
Abingdon Health has been certified for up to $370,000 in performance-based Wisconsin tax credits over three years. The credits support job creation and capital investment at the Group's facility in Madison, Wisconsin.
Hardide plc announced a significant further order intake in North America. The orders will be fulfilled from its US facility, supported by operational improvements that have accelerated delivery rates.
Andrada Mining secured conditional approval for £4.4m in 10-year debt financing from Namibian institutions for its Uis Mine. The company also completed an expanded 16,500-metre diamond drilling programme at Lithium Ridge, with 85% of assay results still pending.
Arc Minerals executed a comprehensive settlement agreement ending all eight outstanding legal disputes in Zambia. The deal provides mutual releases and confirms that the company's subsidiary, Handa Resources, holds Large-Scale Exploration Licence 19906-HQ-LEL without further legal interference.
Physiomics has secured several new and follow-on contracts with biotechnology and oncology organisations. The projects provide near-term revenue and visibility through to the end of 2027.
Deltic Energy received US$1.0m (£738,561.62) from Dana Petroleum relating to the farm-out of Licence P2437. The proceeds will be used for the company's ongoing working capital requirements.
Lynne Weedall will step down as Senior Independent Director and Chair of the Remuneration and Nomination Committees at the 15 July 2026 AGM. A succession process is well progressed.
XPS Pensions Group PLC will announce its full-year results for the year ended 31 March 2026 on 18 June 2026. The group will host a presentation for analysts and investors via webcast and in person on the same day.
Derek McAllan stepped down as Non-Executive Director and Audit Committee Chair with immediate effect due to ill health. Rob Cridland has been appointed interim Chair of the Audit Committee until a replacement is found.
Founder Brian Marsh stepped down after 35 years. Rebecca Shelley was appointed Independent Non-Executive Chair, and Barrie Cornes joined as an Independent Non-Executive Director, both effective 26 May 2026.
AstraZeneca announced that the US FDA extended the PDUFA review date for camizestrant in advanced breast cancer. The extension allows for the review of additional data, including ctDNA clearance, following a split advisory committee vote in April.
Union Jack Oil board recommends voting against re-appointing former director Craig Howie. It proposes sub-dividing shares to enable future fundraising as the stock trades below its 5p nominal value.
Braemar Plc appointed Richard Prince as an independent non-executive director effective 27 May 2026. Catriona Valentine will step down from the board at the Annual General Meeting on 2 July 2026 following a three-year tenure.